COR · Cencora, Inc.
$311.15
+2.71% last session
End-of-day data · updated 2026-07-29
Market cap
$62B
Enterprise value
$74B
Trailing P/E
23.9
Forward P/E
16.1
Dividend yield
1.0%
Beta
0.58
Avg volume
2M
Employees
47K
2D change
2.71%
5D change
3.13%
10D change
3.79%
30D change
13.47%
60D change
18.64%
MTD change
10.80%
YTD change
-5.00%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — COR
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-06-24
Latest call per bank · past 12 months
Bank of America
Neutral$285
-8.4% vs priceBarclays
Overweight$350
+12.5% vs priceWells Fargo
Overweight$331
+6.4% vs priceUBS
Buy$412
+32.4% vs priceCitigroup
Buy$355
+14.1% vs priceJP Morgan
Overweight$419
+34.7% vs priceMorgan Stanley
Overweight$400
+28.6% vs priceJefferies
Buy$440
+41.4% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-06-24 | Bank of America | Maintains | Neutral | $280 → $285 |
| 2026-06-10 | Barclays | Maintains | Overweight | $425 → $350 |
| 2026-05-11 | Wells Fargo | Maintains | Overweight | $429 → $331 |
| 2026-05-07 | UBS | Maintains | Buy | $410 → $412 |
| 2026-05-07 | Citigroup | Maintains | Buy | $405 → $355 |
| 2026-05-07 | Evercore ISI Group | Maintains | Outperform | $360 → $300 |
| 2026-05-07 | Baird | Maintains | Outperform | $420 → $339 |
| 2026-04-28 | William Blair | Initiates | Market Perform | $0.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 69 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 12.4% above the 50-day MA ($284.34).
- Price vs 200-day MA: Trading 1.3% below the 200-day MA ($323.67).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is positive (+0.65) — short-term momentum is improving.
- 52-week range: Price sits between the 52-week low ($252.16) and high ($373.25).
COR Price Chart
Loading chart for COR…
Fundamentals
About Cencora, Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
More in Medical Distribution
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.